Loading
A phase 3 trial of Adaptive radiotherapy in Cervical cancer, run by Peking Union Medical College Hospital, now recruiting.
Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer is a phase 3 interventional study registered as NCT06641635 by Peking Union Medical College Hospital, with 440 participants planned, started 2024-11-19 and due to reach its primary completion in 2026-10-31. Interventions recorded: Moderated hypofractionated online adaptive radiotherapy, Conventional radiotherapy. Conditions recorded: Cervical Cancer, Adaptive Radiotherapy.
Linked to the technology Adaptive radiotherapy because the registry names it ("adaptive radiotherapy") among its interventions and Cervical cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Adaptive radiotherapy (online replanning) and the tag pipeline.
Shares Adaptive radiotherapy (online replanning) and the tag pipeline.
Shares Cervical cancer and the tag pipeline.
Shares Cervical cancer and the tag pipeline.
Shares Cervical cancer and the tag pipeline.
Shares Cervical cancer and the tag pipeline.
Shares Cervical cancer and the tag pipeline.
Shares Cervical cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/